$12.02
-0.07-0.58%
Last update: Oct 27, 11:29 AM
Amarin Corp PLC (AMRN) Stock Price, Quote, News & History
AMRNNASDAQ
Amarin signs $175 million Vazkepa deal with Recordati, plans global restructuring and targets $70 million in cost cuts to improve cash flow
You can purchase shares of Amarin Corp (NASDAQ:AMRN) through any online brokerage.
Other companies in Amarin Corp’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Amarin Corp has a consensus price target of $12.50.
The stock price for Amarin Corp (NASDAQ: AMRN) is $12.02 last updated October 27, 2026 at 11:29 AM EDT.
There are no upcoming dividends for Amarin Corp.
Amarin Corp does not have any upcoming earnings scheduled.
There is no upcoming split for Amarin Corp.
Amarin Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses...
